|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 266, Issue 3 E403-E409, Copyright © 1994 by American Physiological Society
ARTICLES |
D. J. Church, V. van der Bent, M. B. Vallotton, A. M. Capponi and U. Lang
Department of Medicine, Geneva University Hospital, Geneva, Switzerland.
Atrial natriuretic peptide (ANP) is released from the myocardium after the activation of protein kinase C and/or ischemia, events that are associated with an increase in platelet activating factor (PAF) production in this tissue. In this study we demonstrate that PAF, but not lyso-PAF, induces a concentration-dependent increase in ANP secretion in spontaneously beating neonatal rat cardiomyocytes, a response associated with increases in cellular adenosine 3',5'-cyclic monophosphate (cAMP) formation, calcium influx, and the mobilization of calcium from intracellular stores. cAMP formation and calcium influx appear to play major roles in PAF-induced ANP secretion in this system, insofar as PAF-induced ANP release was substantially reduced in the presence of the (R)-p-diastereoisomer of adenosine 3',5'-cyclic monophosphorothioate (10 microM), whereas both PAF-induced calcium influx and ANP secretion were abolished in the presence of the calcium channel antagonist nifedipine (0.1 microM). Consistent with these results, N6-2'-O-dibutyryl cAMP (DBcAMP, 10 microM) and/or forskolin (0.1 microM) simultaneously increased cAMP production, calcium influx, and ANP release in these cells, with both DBcAMP- and forskolin-induced ANP secretion being fully abolished in the presence of 0.1 microM nifedipine. Taken together, these results suggest that PAF, DBcAMP, and forskolin promote ANP secretion in spontaneously beating cardiomyocytes via the activation of a cAMP-dependent, nifedipine-sensitive myocardial calcium channel and that calcium influx is a major requirement for cAMP-induced ANP secretion in this system.
This article has been cited by other articles:
![]() |
D. Li, J. F. Wen, J. Y. Jin, H. Jin, H. S. Ann, S. Z. Kim, S. H. Kim, H. S. Lee, and K. W. Cho Histamine inhibits atrial myocytic ANP release via H2 receptor-cAMP-protein kinase signaling Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R380 - R393. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, J. F. Wen, J. Y. Jin, W. X. Xu, S. Z. Kim, S. H. Kim, H. S. Lee, and K. W. Cho Protein kinase-dependent and Ca2+-independent cAMP inhibition of ANP release in beating rabbit atria Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1477 - R1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rebsamen, D. J. Church, D. Morabito, M. B. Vallotton, and U. Lang Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E922 - E931. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |